|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; 2 Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; 3 Department of Developmental Neurobiology, St. Jude Childrens Research Hospital, Memphis, Tennessee 38105, USA; 4 Department of Ophthalmology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA; 5 Department of Biochemistry, University of Washington, Seattle, Washington 98109, USA
The cell cycle inhibitor p27Kip1 also has cyclincyclin-dependent kinase (CDK)-independent functions. To investigate the significance of these functions in vivo, we generated a knock-in mouse in which four amino acid substitutions in the cdkn1b gene product prevent its interaction with cyclins and CDKs (p27CK). In striking contrast to complete deletion of the cdkn1b gene, which causes spontaneous tumorigenesis only in the pituitary, the p27CK protein dominantly caused hyperplastic lesions and tumors in multiple organs, including the lung, retina, pituitary, ovary, adrenals, spleen, and lymphomas. Moreover, the high incidence of spontaneous tumors in the lung and retina was associated with amplification of stem/progenitor cell populations. Therefore, independently of its role as a CDK inhibitor, p27Kip1 promoted stem cell expansion and functioned as a dominant oncogene in vivo. Thus, the p27CK mouse unveils a dual role for p27 during tumorigenesis: It is a tumor suppressor by virtue of its cyclinCDK regulatory function, and also an oncogene through a cyclinCDK-independent function. This may explain why the cdkn1b gene is rarely inactivated in human tumors, and the p27CK mouse in which the tumor suppressor function is lost but the cyclinCDK-independentoncogenicfunction is maintained may represent a more faithful model for the widespread role of p27 misregulation in human cancers than the p27 null.
[Keywords: p27Kip1; lung tumor; oncogene; retina; bronchioalveolar stem cell; desquamative interstitial pneumonitis]
Received March 30, 2007; revised version accepted May 31, 2007.
E-MAIL jroberts{at}fhcrc.org; FAX (206) 667-6877.
Supplemental material is available at http://www.genesdev.org.
Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.1556607
Related Article
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Genes & Dev. 2007 21: 1703-1706.
This article has been cited by other articles:
![]() |
J. Zhang, S. A. Cicero, L. Wang, R. R. Romito-DiGiacomo, Y. Yang, and K. Herrup Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons PNAS, June 24, 2008; 105(25): 8772 - 8777. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Peacock and D. N. Watkins Cancer Stem Cells and the Ontogeny of Lung Cancer J. Clin. Oncol., June 10, 2008; 26(17): 2883 - 2889. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schiappacassi, F. Lovat, V. Canzonieri, B. Belletti, S. Berton, D. Di Stefano, A. Vecchione, A. Colombatti, and G. Baldassarre p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis Mol. Cancer Ther., May 1, 2008; 7(5): 1164 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sicinski, S. Zacharek, and C. Kim Duality of p27Kip1 function in tumorigenesis Genes & Dev., July 15, 2007; 21(14): 1703 - 1706. [Full Text] [PDF] |
||||